GLP-3 RE 10mg

Inventory Status:

Available

Product Details
AvailabilityIn stock
SKUGLP3RE-10MG
SKU GLP3RE-10MG Categories , Brand:

$168.00

Price per mg
Total (10mg)$16.80/mg

Strict Regulatory Notice: This agent is synthesized strictly for laboratory-based research and analytical purposes. It is not intended for human or veterinary use, nor for medical, household, or cosmetic applications. Please review our Terms of Service thoroughly before finalizing your acquisition.

Concentration and Formulation
Contents10mg per vial
FormLyophilized powder

Available

For Research Use Only. Not for human or veterinary use.
Key Documents
SDS = Safety Data Sheet  ·  COA = Certificate of Analysis

Guaranteed Safe Checkout:

payment icons.jpg

Key Specifications

ParameterSpecification / Details
Primary Compound NameRetatrutide (Triple-Agonist Peptide)
CAS Registry Number2381089-83-2
IUPAC Designation(Sequence incorporates Aib, α-MeL, and a C20 fatty diacid moiety at position 17)
Synonyms / Trade NamesGLP-3 RE, LY-3437943, Triple-G Agonist
PubChem CID171390338
Molecular FormulaC221​H342​N46​O68​
Molar Mass / Weight4731.33 g/mol
Physical AppearanceWhite lyophilized (freeze-dried) solid/powder
Solubility ProfileHighly soluble in Bacteriostatic Water.
Tested Purity≥98% via HPLC
Active Ingredient (Total)10mg per vial
Dry / Powder FormulationsLyophilized powder
Alternative FormulationsSemaglutide (GLP-1), Tirzepatide (GLP-1/GIP)
Storage GuidelinesLyophilized: Store at -20°C for long-term stability. Protect from light.Reconstituted: Must be refrigerated at 2°C to 8°C.
Estimated Shelf Life24 months from manufacture date (lyophilized).
Safety DocumentationStandard SDS available for Retatrutide
Terms of ApplicationFor laboratory research purposes only. Not for human or veterinary use. Investigated as a highly potent tri-agonist to study the synergistic metabolic regulation of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R) in in-vitro energy expenditure and lipid metabolism models.

Foundational Scientific Overview

Foundational Scientific Overview

GLP-3 RE (10mg) represents the cutting edge of multi-target metabolic research. Synthesized as a tri-agonist, it concurrently activates the GLP-1, GIP, and Glucagon (GCG) receptors. It serves researchers examining complex hepatic lipid clearance, maximal energy expenditure, and systemic metabolic reprogramming in pre-clinical models.

At 4-Amino-Labs, we provide this highly complex peptide to ensure experimental reproducibility across varied multi-receptor assays.

The development of tri-agonists that incorporate glucagon receptor activation to drastically increase energy expenditure while utilizing GLP-1/GIP for glycemic control is highly established in recent molecular literature. See: Tschöp, M. H., et al. (2016). "Unimolecular Polypharmacy for Treatment of Diabetes and Obesity." Cell Metabolism, 24(1), 51-62.

Analytical Composition and Purity

Purity≥98%via HPLC
FormulaProprietary Tri-Agonist Peptide Sequence
Physical StateWhite Lyophilized Solid

Investigational Pathways

Tri-Receptor Kinetics
Evaluating the compound’s simultaneous binding and activation thresholds across hepatic and pancreatic cell lines.
Hepatic Steatosis Reversal
Observing the profound reduction of lipid accumulation in isolated hepatocyte models via GCG activation.
Maximal Thermogenesis
Mapping the flux of uncoupling proteins (UCPs) and cellular energy output.

Laboratory Handling and Stability

Thermal Regulation
Store in a strictly controlled, refrigerated, and desiccated environment (-20°C preferred for long-term).
Photostability
Protect from direct UV exposure.

Compliance and Safety

This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4-Amino-Labs does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.

Analytical Composition & Purity Standards

  • Chemical Formula: Proprietary Tri-Agonist Peptide Sequence
  • Physical State: White Lyophilized Solid

Our GLP-3 RE undergoes a multifaceted verification process via independent High-Performance Liquid Chromatography (HPLC) to verify the precise structural integrity of the complex chain, ensuring a purity threshold of ≥ 98%.

 

Investigational Pathways

Researchers utilizing GLP-3 RE typically focus on the following biochemical mechanisms:

  • Tri-Receptor Kinetics: Evaluating the compound’s simultaneous binding and activation thresholds across hepatic and pancreatic cell lines.
  • Hepatic Steatosis Reversal: Observing the profound reduction of lipid accumulation in isolated hepatocyte models via GCG activation.
  • Maximal Thermogenesis: Mapping the flux of uncoupling proteins (UCPs) and cellular energy output.

Laboratory Handling & Stability Protocol

To maintain the molecular integrity of GLP-3 RE, the following storage parameters are recommended:

  • Thermal Regulation: Store in a strictly controlled, refrigerated, and desiccated environment (-20°C preferred for long-term).
  • Photostability: Protect from direct UV exposure.

Compliance & Safety Disclaimer

This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4-Amino-Labs does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.

0
Please choose an option first.
GLP-3 RE 10mg